Tocqueville Asset Management’s Novavax NVAX Stock Holding History

Tocqueville Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,300	Closed	-$270K	–	760
2021 Q3	$270K	Buy	+1,300	New	+$287K	﹤0.01%	647
2016 Q3	–	Sell	-3,500	Closed	-$509K	–	839
2016 Q2	$509K	Hold	3,500	–	–	0.01%	633
2016 Q1	$361K	Buy	3,500 +500	+17%	+$53.6K	﹤0.01%	690
2015 Q4	$503K	Buy	+3,000	New	+$462K	0.01%	660
2015 Q3	–	Sell	-5,000	Closed	-$1.11M	–	994
2015 Q2	$1.11M	Sell	5,000 -1,250	-20%	-$220K	0.01%	549
2015 Q1	$1.03M	Hold	6,250	–	–	0.01%	577
2014 Q4	$741K	Buy	6,250 +1,250	+25%	+$131K	0.01%	630
2014 Q3	$417K	Hold	5,000	–	–	﹤0.01%	662
2014 Q2	$462K	Buy	5,000 +2,000	+67%	+$176K	﹤0.01%	745
2014 Q1	$272K	Sell	3,000 -250	-8%	-$27.9K	﹤0.01%	724
2013 Q4	$333K	Sell	3,250 -2,500	-43%	-$177K	﹤0.01%	684
2013 Q3	$362K	Buy	5,750 +4,000	+229%	+$225K	﹤0.01%	722
2013 Q2	$72K	Buy	+1,750	New	+$75.8K	﹤0.01%	911

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tocqueville Asset Management's NVAX Position: Q4 2021 in Review

Tocqueville Asset Management sold out of Novavax (NVAX) in Q4 2021, closing a stake of 1,300 shares — an estimated $270K sold.

Tocqueville Asset Management first reported a position in NVAX in Q2 2013 and held it in 13 quarters. The position peaked at $1.11M in Q2 2015. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

Tocqueville Asset Management reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
Tocqueville Asset Management sold 1,300 Novavax shares in Q4 2021, an estimated $270K.
Tocqueville Asset Management first reported a position in Novavax in Q2 2013 and held it in 13 quarters.
Tocqueville Asset Management's Novavax position peaked at $1.11M in Q2 2015.
429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Tocqueville Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.